Filters
Driving pharmaceutical excellence and growth in Pavia: A Q&A with Roberto Gagliano, General Manager, Hikma Italia
Insight, Life at Hikma
03 October 2025
New
Hikma and Richter receive FDA approval for denosumab biosimilars EnobyTM (denosumab- qbde) and XtrenboTM (denosumab- qbd...
Press Release, Product
29 September 2025
New
Hikma R&D Innovating formulation development. Meet Helena Sremec
Story, Life at Hikma
29 September 2025
New
Inspiring women of Hikma. Meet Jaclyn Bachman, Associate Director Validations & Metrology, Cherry Hill, US
Story, Life at Hikma
16 September 2025
New
Hikma R&D Formulation Development Innovation. Meet Timothy Owen
Story, Life at Hikma
15 September 2025
New
Hikma R&D Analytical Research Innovation. Meet Seham Samawi
Story, Life at Hikma
03 September 2025
New
Hikma R&D Formulation Development Innovation. Meet Mihir Modh
Story, Life at Hikma
26 August 2025
New
Acting responsibly for purpose-driven impact: How Hikma champions inclusive education
Insight, Responsibility
25 August 2025
New
Inspiring women of Hikma. Meet Dr Nina Diaz, General Manager of Hikma Thymoorgan, Germany
Story, Leadership
22 August 2025
New
Strategic insights into Hikma Injectables CMO. Q&A with Tiago Duarte
Insight, Corporate
14 August 2025
New
Hikma R&D Innovating Clinical Research. Meet Rand Alsaber
Story, Life at Hikma
13 August 2025
New
Hikma delivers a solid H1 performance and re-affirms expectations for strong growth in the second half
Press Release, Financial Results
07 August 2025
New
Hikma R&D Innovating analytical research. Meet Raghad Saleh
Story, Life at Hikma
28 July 2025
New
Hikma R&D Innovating Analytical Research. Meet Saras Konar
Story, Life at Hikma
17 July 2025
Hikma remains a constituent of the FTSE4Good Index
Press Release, Corporate
16 July 2025
You have viewed 15 of 529 results